The 510(k) database is a searchable index of premarket notifications showing whether FDA determined a device to be substantially equivalent to a legally marketed predicate. Searches run through the FDA Premarket Notification interface and can be filtered by panel, 510(k) number, product code, device name, applicant name, decision type and decision date [3][7]. A basic query produces a record that includes device classification name, regulation number, applicant, contact, product code, date received, decision date, decision, advisory committee and whether a summary or statement is available [8]. Manufacturers, consultants and competitive analysts use the database to locate predicate devices, review clearance histories and monitor product-code activity. What a record does not do is demonstrate clinical superiority, broad safety claims or a specific procurement fit. openFDA warns against relying on the endpoint for medical care decisions [5]. The database remains a regulatory history tool, not an efficacy evaluation.

What a 510(k) clearance means in the database

A 510(k) record reflects a premarket notification submitted before introducing a device into commercial distribution for the first time, or before reintroducing a device that has been significantly changed in a way that could affect safety or effectiveness [1]. The notification gives FDA the chance to determine whether the device is equivalent to a device already placed into a classification category [1]. The database therefore documents an administrative equivalence finding rather than an independent demonstration of new clinical benefit.

The database landing page states that a 510(k) shows the device is "as safe and effective, that is, substantially equivalent, to a legally marketed device" that is not subject to PMA [3]. The comparator is commonly called a predicate [5]. Records may carry decision values beyond a simple substantial equivalence designation, including substantial equivalence with postmarket surveillance required, with limitations, subject to tracking regulations, or substantial equivalence for some indications [3][7]. Those qualifiers matter when one clearance is compared with another.

Which search fields matter for professional research

The Premarket Notification search form exposes several filter groups. A researcher can enter a 510(k) number, select a type such as traditional, special or abbreviated, choose a center, product code, applicant name, panel and decision date range [3][7]. The form also supports a quick search interface [3]. Search result ordering can be set by decision date, device name, applicant name or 510(k) number, either ascending or descending [3].

The releasable database can be searched by panel, 510(k) number, product code or device name [8]. A returned record includes the device classification name, regulation number, 510(k) number, device name, applicant, contact, product code, date received, decision date, decision, classification advisory committee, review advisory committee and a summary or statement indicator [8]. The type field distinguishes traditional, special and abbreviated submissions, and records can show whether third-party review or expedited review applied [8]. These fields define the practical scope of most predicate research.

Running a basic clearance search

Open the FDA Premarket Notification search page and choose one focused field first, such as product code or device name. Select a panel only when the product code is unknown [3][8]. Enter a decision date range if you want recent activity, then sort by decision date descending [3]. Review the decision field and the SUMMARY or STATEMENT indicator in each returned record [8].

A hypothetical predicate-evaluation workflow

A regulatory analyst evaluating a new device would start with the product code. The search page links to the FDA product code classification interface, allowing a researcher to identify the classification name, regulation and panel before querying cleared records in that code [3][8]. Narrowing by panel, then by decision date descending, shows recent clearance activity. The analyst would record the 510(k) number, applicant, device name and decision for each candidate.

The next step is comparing decision qualifiers. A record marked "SE - WITH LIMITATIONS" differs from a plain substantial equivalence record, while a postmarket surveillance requirement signals a different post-clearance obligation [3][7]. The analyst would also note whether the record says SUMMARY or STATEMENT; a summary indicates safety and effectiveness information is available from FDA, while a statement indicates it may be obtained from the applicant [8]. This distinction determines how much public documentation may be obtainable for a chosen predicate. This workflow is a suggested evaluation sequence, not an FDA-mandated method.

The openFDA option and its boundaries

For higher-volume work, openFDA provides a machine-readable endpoint containing details about specific products and original sponsors of premarket notification applications, along with receipt and decision dates [5]. The API is updated monthly and covers data from 1976 onward [5]. openFDA annotates the original clearance records and converts the data to JSON for programmatic querying [5].

The endpoint carries explicit use limits. openFDA warns that users should not rely on the service to make decisions regarding medical care and should discuss risks and benefits with a health provider [5]. Access may also be restricted under the platform's terms of service [5]. For analysts, this means openFDA is appropriate for tracking submissions at scale, but it should not become the sole basis for selecting a predicate or making a regulatory submission decision. Primary records in the FDA interface remain the reference copy.

What the records cannot establish

A clearance record is not evidence of clinical effectiveness for a new indication, patient population or use setting. The database documents a substantial equivalence determination against a predicate, with the required notification submitted at least 90 days before marketing [6]. It does not provide comparative performance data, independent adverse-event analysis or instructions for use. The availability of a SUMMARY indicator does not itself guarantee that a full technical file is public [8].

Likewise, a 510(k) number in the database does not mean that a device remains commercially active or that later changes did not trigger a new notification. FDA guidance covers when a change to an existing device requires another 510(k), including software changes [1]. A clearance found in a yearly archive is a historical record at a point in time, not a current market status [1]. Researchers should treat database results as regulatory history and pair them with the resubmission and change-control guidance applicable to their product.